18.69
-0.57 (-2.96%)
-0.57 (-2.96%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Amphastar Pharmaceuticals Inc | AMPH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.57 | -2.96% | 18.69 | 19:53:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 19.22 | 18.67 | 19.4484 | 18.69 | 19.26 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 18.34 | 18.78 | 0.44 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,478 | 155,294 | $ 18.96 | $ 2,944,818 | 225,220 | 12.325 - 22.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:09:19 | 4 | $ 18.88 | USD |
Amphastar Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 887.85M | 47.50M | 30.28M | $ 322.36M | $ 8.74M | 0.99 | 142.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -1.50k | 2.20% |
Amphastar Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 19.02 | 20.00 | 18.67 | 19.60 | 178,047 | -0.33 | -1.74% |
| 1 Month | 18.28 | 20.93 | 18.20 | 19.58 | 219,911 | 0.41 | 2.24% |
| 3 Months | 20.74 | 21.33 | 17.51 | 19.17 | 206,498 | -2.05 | -9.88% |
| 6 Months | 20.72 | 21.445 | 17.51 | 19.65 | 200,487 | -2.03 | -9.8% |
| 1 Year | 19.07 | 22.70 | 12.325 | 18.65 | 248,298 | -0.38 | -1.99% |
| 3 Years | 18.53 | 25.43 | 12.325 | 19.23 | 213,205 | 0.16 | 0.86% |
| 5 Years | 12.10 | 25.43 | 10.50 | 18.07 | 247,852 | 6.59 | 54.46% |
Amphastar Pharmaceuticals Description
| Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. The business activities are operated through two reportable segments namely finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, naloxone, lidocaine, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API. Its products are used in hospitals or urgent care clinical settings. Geographically the business presence of the firm is seen in the United States and France of which the US accounts for the majority of revenue. |
